Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Bode

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|February 16, 2018
Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with MicroalbuminuriaSharad Purohit, Ashok Sharma, Wenbo Zhi, et al.
Diabetes, Obesity & Metabolism|December 20, 2018
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp studyTim Heise, Grégory Meiffren, Bertrand Alluis, et al.
Lancet (London, England)|April 24, 2012
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trialSimon Heller, John Buse, Miles Fisher, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetesBerrin Ergun-Longmire, John Marker, Adina Zeidler, et al.
Diabetes Care|January 27, 2011
Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial, Darrell M Wilson, Dongyuan Xing, et al.
Diabetes Care|May 3, 2013
The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetesYulan Jin, Ashok Sharma, Colleen Carey, et al.
Diabetes Care|March 18, 2020
Evaluation of Factors Related to Glycemic Management in Professional Cyclists With Type 1 Diabetes Over a 7-Day Stage RaceSam N Scott, Mark P Christiansen, Federico Y Fontana, et al.
JAMA Network Open|November 15, 2021
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic RetinopathyEli Ipp, David Liljenquist, Bruce Bode, et al.
The Lancet. Diabetes & Endocrinology|March 4, 2021
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trialMatthias von Herrath, Stephen C Bain, Bruce Bode, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular ComplicationsPaul Minh Huy Tran, Eileen Kim, Lynn Kim Hoang Tran, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|February 16, 2018
Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with MicroalbuminuriaSharad Purohit, Ashok Sharma, Wenbo Zhi, et al.
Diabetes, Obesity & Metabolism|December 20, 2018
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp studyTim Heise, Grégory Meiffren, Bertrand Alluis, et al.
Lancet (London, England)|April 24, 2012
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trialSimon Heller, John Buse, Miles Fisher, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetesBerrin Ergun-Longmire, John Marker, Adina Zeidler, et al.
Diabetes Care|January 27, 2011
Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial, Darrell M Wilson, Dongyuan Xing, et al.
Diabetes Care|May 3, 2013
The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetesYulan Jin, Ashok Sharma, Colleen Carey, et al.
Diabetes Care|March 18, 2020
Evaluation of Factors Related to Glycemic Management in Professional Cyclists With Type 1 Diabetes Over a 7-Day Stage RaceSam N Scott, Mark P Christiansen, Federico Y Fontana, et al.
JAMA Network Open|November 15, 2021
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic RetinopathyEli Ipp, David Liljenquist, Bruce Bode, et al.
The Lancet. Diabetes & Endocrinology|March 4, 2021
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trialMatthias von Herrath, Stephen C Bain, Bruce Bode, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular ComplicationsPaul Minh Huy Tran, Eileen Kim, Lynn Kim Hoang Tran, et al.
Pageof 7